share_log

愛帝宮：翌日披露報表

AIDIGONG: Next Day Disclosure Return

HKEX ·  Jul 29 18:32

Summary by Moomoo AI

愛帝宮母嬰健康股份有限公司於2024年7月29日完成了一項資本重組，該重組涉及將公司股本中每股面值0.01港元的普通股和A類及B類可換股優先股，每四十股合併為每股面值0.4港元的合併股份。此次股份合併已於2024年7月25日的股東特别大會上獲得通過，並於2024年7月29日正式生效。合併前，公司的已發行普通股總數為5,913,353,298股，合併後的結存為147,833,832股；A類可換股優先股合併前為187,265,918股，合併後結存為4,681,647股；B類可換股優先股合併前為187,265,918股，合併後結存為4,681,647股。股份合併導致的股份數目變動均達到97.5%。愛帝宮母嬰健康股份有限公司已依照香港聯合交易所有限公司證券上市規則的要求，於翌日披露報表中公布了該變動。
愛帝宮母嬰健康股份有限公司於2024年7月29日完成了一項資本重組，該重組涉及將公司股本中每股面值0.01港元的普通股和A類及B類可換股優先股，每四十股合併為每股面值0.4港元的合併股份。此次股份合併已於2024年7月25日的股東特别大會上獲得通過，並於2024年7月29日正式生效。合併前，公司的已發行普通股總數為5,913,353,298股，合併後的結存為147,833,832股；A類可換股優先股合併前為187,265,918股，合併後結存為4,681,647股；B類可換股優先股合併前為187,265,918股，合併後結存為4,681,647股。股份合併導致的股份數目變動均達到97.5%。愛帝宮母嬰健康股份有限公司已依照香港聯合交易所有限公司證券上市規則的要求，於翌日披露報表中公布了該變動。
On July 29, 2024, Love Palace Mother and Baby Health Co., Ltd. completed a capital restructuring that involved the consolidation of each share of the company's common stock, A and B convertible preferred shares with a face value of HKD0.01 per share, into one share of consolidated stock with a face value of HKD0.4 per forty shares. The stock consolidation was approved at a special general meeting of shareholders on July 25, 2024 and became effective on July 29, 2024. Prior to the consolidation, the total number of issued common shares of the company was 5,913,353,298 shares, and the post-consolidation balance was 147,833,832 shares; the number of A convertible preferred shares before the consolidation was 187,265,918 shares, and the post-consolidation balance was 4,681,647 shares; and the number of B...Show More
On July 29, 2024, Love Palace Mother and Baby Health Co., Ltd. completed a capital restructuring that involved the consolidation of each share of the company's common stock, A and B convertible preferred shares with a face value of HKD0.01 per share, into one share of consolidated stock with a face value of HKD0.4 per forty shares. The stock consolidation was approved at a special general meeting of shareholders on July 25, 2024 and became effective on July 29, 2024. Prior to the consolidation, the total number of issued common shares of the company was 5,913,353,298 shares, and the post-consolidation balance was 147,833,832 shares; the number of A convertible preferred shares before the consolidation was 187,265,918 shares, and the post-consolidation balance was 4,681,647 shares; and the number of B convertible preferred shares prior to the consolidation was 187,265,918 shares, and the post-consolidation balance was 4,681,647 shares. The number of shares affected by the stock consolidation reached 97.5%. Love Palace Mother and Baby Health Co., Ltd. has disclosed this change in accordance with the listing rules of the Hong Kong Stock Exchange on the following day.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated